tiprankstipranks
Foghorn Therapeutics (FHTX) Collaborates with Eli Lilly and Surpasses Q3 Expectations
PremiumMarket NewsFoghorn Therapeutics (FHTX) Collaborates with Eli Lilly and Surpasses Q3 Expectations
1M ago
Foghorn Therapeutics Reports Third Quarter Highlights
Premium
Company Announcements
Foghorn Therapeutics Reports Third Quarter Highlights
2M ago
Foghorn Therapeutics Advances Oncology Pipeline with New Trials
Premium
Company Announcements
Foghorn Therapeutics Advances Oncology Pipeline with New Trials
2M ago
Foghorn Therapeutics price target raised to $9 from $6 at Morgan Stanley
PremiumThe FlyFoghorn Therapeutics price target raised to $9 from $6 at Morgan Stanley
3M ago
Foghorn Therapeutics appoints Anna Rivkin as CBO
Premium
The Fly
Foghorn Therapeutics appoints Anna Rivkin as CBO
4M ago
Foghorn Therapeutics initiated with a Buy at Jefferies
Premium
The Fly
Foghorn Therapeutics initiated with a Buy at Jefferies
4M ago
Foghorn Therapeutics prices 12.7M shares at $5.51 in registered direct offering
PremiumThe FlyFoghorn Therapeutics prices 12.7M shares at $5.51 in registered direct offering
7M ago
Foghorn Therapeutics provides update on programs, upcoming milestones
Premium
The Fly
Foghorn Therapeutics provides update on programs, upcoming milestones
8M ago
Foghorn Therapeutics reports Q1 EPS (59c), consensus (63c)
Premium
The Fly
Foghorn Therapeutics reports Q1 EPS (59c), consensus (63c)
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100